<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3381,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/1c6421174b74ffac9e6c8f5d9a952ae5'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/1c6421174b74ffac9e6c8f5d9a952ae5'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1I82JS003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1I82JS003">Previous Result: <span>United States v. Craig, 694 F.3d 509 (3d...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1ILR40003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1ILR40003">Next Result: <span>United States v. Briggs, No. 12-2988-cr,...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court Opinion'>
United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court...
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court Opinion</div>
<div class='docId'>X1ILR46003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>United States ex rel. Williams v. Renal Care Grp., Inc.</div>
<div class='displayCitation'>2012 BL 261568</div>
<div class='displayCitation'>696 F.3d 518</div>
<div class='displayCitation'>bna a0d4y6x4t7</div>
<div class='displayCitation'>bna decref81753</div>
<div class='displayCitation'>wkf6case:26572355</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1ILR46003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="United States ex rel. Williams v. Renal Care Grp., Inc." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1ILR46003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1ILR46003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1ILR46003" /><input id="title" name="title" type="hidden" value="United States ex rel. Williams v. Renal Care Grp., Inc., 696 F.3d 518 (6th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="1c6421174b74ffac9e6c8f5d9a952ae5" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1ILR46003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%31c%36%34%32%31%31%37%34b%37%34ffac%39e%36c%38f%35d%39a%39%35%32ae%35%2Fdocument%2FX%31ILR%34%36%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/bcite/X1ILR46003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/bcite/X1ILR46003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/bcite/X1ILR46003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/related_content/X1ILR46003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1741445857283";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">696 F.3d 518</div>
<div class="cite" data-cite-type="DocketNumber">11-5779</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 261568</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Sixth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
UNITED STATES of America, ex rel. Julie WILLIAMS, Plaintiffs-Appellees, John
Martinez, M.D., Plaintiff, v. RENAL CARE GROUP, INC.; Renal Care Group
Supply Company; Fresenius Medical Care Holdings, Inc.,
Defendants-Appellants.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-5779.
</center></p>
<p><center>
Argued: July 25, 2012.
</center></p>
<p><center>
Decided and Filed: October 5, 2012.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Middle District of
Tennessee, William J. Haynes, Jr.
<span CLASS="page_no" data-cite="696 f 3d 519" data-cite-type="PrimaryFederalReporter" data-cite-pageno="519" data-primary-citation="696 F.3d 518">[*519]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="696 f 3d 520" data-cite-type="PrimaryFederalReporter" data-cite-pageno="520" data-primary-citation="696 F.3d 518">[*520]</span> 
<b>ARGUED:</b> James F. Bennett, Dowd Bennett, LLP, St. Louis, Missouri, for
Appellants. Michael P. Abate, United States Department of Justice,
Washington, D.C., for Appellees. <b>ON BRIEF:</b> James F. Bennett, Megan S.
Heinsz, Dowd Bennett, LLP, St. Louis, Missouri, Michael L. Dagley, Matthew
M. Curley, Bass Berry &amp; Sims, Nashville, Tennessee, for Appellants. Michael
P. Abate, Michael S. Raab, United States Department of Justice, Washington,
D.C., for Appellees.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: COLE and COOK, Circuit Judges; ROSEN, Chief District Judge.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> The Honorable Gerald E. Rosen, Chief Judge of the United States
District Court for the Eastern District of Michigan, sitting by desig
nation.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  COLE, Circuit Judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  COLE, J., delivered the opinion of the court in which, COOK, J., and
ROSEN, C. D.J., joined. ROSEN, C. D.J. (pp. 533-35), delivered a separate
concurring opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Renal Care Group, Inc., a dialysis provider, created a wholly-owned
subsidiary to take advantage of loopholes in the Medicare
<span CLASS="page_no" data-cite="696 f 3d 521" data-cite-type="PrimaryFederalReporter" data-cite-pageno="521" data-primary-citation="696 F.3d 518">[*521]</span> 
regulatory scheme that would permit it to increase profits. The United
States, by and through its relators, brought suit against Renal Care Group,
its subsidiary, and its successor, alleging that such actions constituted a
number of False Claims Act violations. The district court granted summary
judgment in favor of the United States as to the main claim, Count One &mdash; the
only claim upon which damages were sought &mdash; and then proceeded to enter
summary judgment as to the ancillary claims as well, though without
explanation. For the reasons set forth below, we REVERSE the district
court's judgments as to Counts One and Two, and GRANT summary judgment on
those counts in favor of the defendants. Further, we REVERSE the district
court's judgments as to all remaining counts and REMAND for proceedings
consistent with this opinion, but DENY the defendants' motion for
reassignment of this case to another district judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I. BACKGROUND
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A. Factual Background</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Renal Care Group, Inc. (RCG) was, for all times relevant to the instant
case, the parent company of Renal Care Group Supply Company (RCGSC).
Fresenius Medical Care Holdings, Inc., (Fresenius) is the
successor-in-interest to both RCG and RCGSC. RCG provided dialysis to
patients with end-stage renal disease (ESRD) at more than 260 RCG dialysis
facilities, in addition to providing dialysis supplies and services to home
dialysis patients. RCGSC, meanwhile, supplied only dialysis equipment to
home dialysis patients. Both entities submitted claims for payment for these
services to Medicare.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. End-stage renal disease and Medicare</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  ESRD occurs when the kidneys are no longer able to function at a level
needed for daily life because they are unable to remove waste and excess
water from <span CLASS="page_no" data-cite="2012 bl 261568 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> the body. Persons suffering from ESRD must undergo some form of
kidney disease treatment, which may include either hemodialysis or
peritoneal dialysis. Patients undergoing hemodialysis use a machine that
removes blood from the body, runs it through a filter, and then returns the
blood to the body. In peritoneal dialysis, a dialysis solution travels
through a catheter into a patient's abdomen and draws wastes, chemicals, and
extra water from blood vessels in the peritoneal membrane. The solution is
then removed, and the process repeated. There are two types of peritoneal
dialysis: continuous ambulatory peritoneal dialysis (CAPD), which requires
no machine, and continuous cycler-assisted peritoneal dialysis (CCPD), in
which a machine called a "cycler" fills and empties the abdomen while the
patient sleeps.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 1972, Congress expanded Medicare to provide insurance coverage for
patients suffering from ESRD, regardless of their age. Pub. L. No. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=USACTS%2092-603&amp;summary=yes#jcite">92-603</a>, <cite>&sect;
2991</cite>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=86%20stat%201329&amp;summary=yes#jcite">86 Stat. 1329</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=86%20stat%201329&amp;summary=yes#jcite">1463-64</a> (1972). In 1978, citing a need to lower costs,
Congress amended the program to permit Medicare to reimburse dialysis
facilities for the cost of home dialysis equipment. Pub. L. No. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=USACTS%2095-292&amp;summary=yes#jcite">95-292</a>, <cite>&sect; 2</cite>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=92%20stat%20307&amp;summary=yes#jcite">92 Stat. 307</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=92%20stat%20307&amp;summary=yes#jcite">308</a> (1978). Initially, all services, including home dialysis,
were reimbursed at a uniform composite weighted payment. Pub. L. No. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=USACTS%2097-35&amp;summary=yes#jcite">97-35</a>,
<cite>&sect; 2145(a)</cite>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=95%20stat%20357&amp;summary=yes#jcite">95 Stat. 357</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=95%20stat%20357&amp;summary=yes#jcite">799-800</a> (1981). This reimbursement rate is known as
"Method I" reimbursement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The uniform Method I reimbursement rate did not apply to independent
companies that provided only equipment and supplies (but not services)
directly to home dialysis patients. Those companies were reimbursed under a
"Method II" protocol,
<span CLASS="page_no" data-cite="696 f 3d 522" data-cite-type="PrimaryFederalReporter" data-cite-pageno="522" data-primary-citation="696 F.3d 518">[*522]</span> 
whereby payment is made on a "fee-for-service basis, which is the reasonable
charge method used for [Medicare] Part B services." <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=57%20federal%20register%2054179&amp;summary=yes#jcite">57 Fed. Reg. 54,179</a>
(Nov. 17, 1992). Method II reimbursements eventually became more expensive
than Method I reimbursements. <i>See</i> H.R. Conf. Rep. No. 101-386, <i>reprinted</i>
<i>in</i>1989 U.S.C.C.A.N. 3018, 3429. Congress eventually capped Method II
payments at the Method I rate, except for payments for supplies for CCPD
treatments, which were capped at 130% of the Method I rate.
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(7)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(7).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Congress further restricted Method II reimbursements with
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(4)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(4)(B), which permits such reimbursements only "to a
supplier of home dialysis supplies and equipment furnished to a patient
whose self-care home dialysis <i>is not under the direct supervision of an</i>
<i>approved provider of services or renal dialysis facility. . . .</i>" (emphasis
added). This was clarified in 1994, when Congress required that Method II
payments may only go to an entity that is not "a provider of services [or] a
renal dialysis facility. . . ." <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(1); <i>see</i>
<i>also</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XDLUMC003?jcsearch=42%20cfr%20400%20202&amp;summary=yes#jcite">42 C.F.R. &sect; 400.202</a> (defining a supplier as "a physician or other
practitioner, or an entity other than a provider, that furnishes health care
services under Medicare"). Such an entity must obtain a supplier number
before it can bill Medicare for supplies and equipment,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAJK003?jcsearch=42%20U.S.C.%20%201395m(j)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395m</a>(j)(1)(A), and may only be reimbursed if it is "not a
Medicare approved dialysis facility," <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XDM5HE003?jcsearch=42%20C.F.R.%20%20414.330(a)(2)(i)&amp;summary=yes#jcite">42 C.F.R. &sect; 414.330</a>(a)(2)(i). In 2010,
the Secretary for Health and Human Services eliminated Method II
reimbursements altogether. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=75%20federal%20register%2049030&amp;summary=yes#jcite">75 Fed. Reg. 49,030</a>, 49,058 (Aug. 12, 2010).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. Conversion of RCG patients to RCGSC patients</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RCGSC had its basis in a <span CLASS="page_no" data-cite="2012 bl 261568 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> 1997 e-mail written by Russell Dimmitt, RCG's
director of material management, which compared Method I and Method II
reimbursements. The e-mail made clear that Method II reimbursements were
substantially higher, and would result in less over-head. A subsequent
memorandum to RCG associates directed them to "convert CCPD Medicare
patients to method 2." The memorandum also instructed associates to place
new CCPD patients on Method II, even those who might initially be CAPD
patients (which had an equivalent reimbursement rate for Method I CAPD
patients), because the companies would "plan to convert them later."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RCGSC was formed in 1998 as a wholly-owned subsidiary of RCG, and RCG
employees, officers, and directors all held key roles in RCGSC's corporate
structure. Gary Brukardt, RCG's chief executive officer, was also RCGSC's
president. The companies shared office space, payroll, insurance benefits,
contracts, and human resource services. Money deposited into RCGSC's account
was swept into RCG's corporate account nightly, RCG's accounts payable
department paid RCGSC's supply vendors, and RCGSC's director could not spend
RCGSC's funds. All RCGSC employees were managed or directed by RCG
employees. From 1999 to 2005, RCG and RCGSC received close to eighty-four
million dollars in Medicare Method II reimbursements, comprising
approximately seventy-seven percent of all Medicare reimbursements the two
entities received.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On October 26, 1998, David Jones, RCG's chief operating officer for RCG's
south central region, expressed his hesitation to convert Method I patients
into Method II patients in an e-mail to Dimmitt. Jones wrote that such a
plan "is not in the best interests of our patients. . . . I do not think it
is legal to force our patients into a Method II arrangement simply to
<span CLASS="page_no" data-cite="696 f 3d 523" data-cite-type="PrimaryFederalReporter" data-cite-pageno="523" data-primary-citation="696 F.3d 518">[*523]</span> 
increase profits of our Company. I do not wish to go to jail. . . ." Jones
left the company in 1999.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>3. RCG's attempts for clarification</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Around the time that Jones told Dimmitt that he believed RCG's plan was
illegal, RCG itself began inquiring into the plan's legality. On October 28,
1998, Dawn Alexander, outside counsel for RCG, prepared a memo on "Method I
v. Method II Issues." Alexander noted that a joint entity between a dialysis
facility, like RCG, and another party could not be eligible for Method II
reimbursements. She reserved judgment, however, on whether a wholly-owned
subsidiary, like RCGSC, could do so, but noted that the Office of Inspector
General (OIG) had issued a fraud alert concerning the use of shell
corporations to maximize Medicare reimbursements. The OIG cautioned that
hallmarks of such shell corporations could be that the parent corporation
owned the capital equipment, and that the parent corporation was responsible
for all day-to-day operations of the shell.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Alexander also sought clarification from Gene Richter, a federal official
with the Health Care Financing Administration (HCFA), on the legality of
establishing an entity like RCGSC (though never mentioning either RCG or
RCGSC). In a letter to Richter, Alexander referred to a previous
conversation <span CLASS="page_no" data-cite="2012 bl 261568 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> with Richter in which Alexander asked whether "a dialysis
facility's wholly-owned subsidiary supply company could act as a Method II
supplier," and noted that Richter's interpretation was that "as long as the
wholly owned supply company has its own provider number and is established
as a separate entity, it may act as a supplier for Method II patients
[legally]." Richter's justification for this interpretation, Alexander
memorialized, was "that there is now a payment cap on Method II payments
that did not exist in the past." Alexander closed the letter by asking for
confirmation that this understanding was correct. She received no response.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RCGSC underwent a Medicare site investigation in 2000 to ensure compliance
with regulatory standards, and no referral of improper operations was made.
Additionally, other supply companies, such as St. Louis Supply Company,
Midwest Renal Support, and Dialysis Associates LLC, made clear in their
Medicare disclosures that RCG either owned them outright or managed their
day-to-day operations. RCGSC repeatedly disclosed to Medicare that it was
owned by "RCGI" or RCG, and that it shared personnel, contracts, and
insurance policies with RCG. RCG eventually closed RCGSC upon its merger
with Fresenius in 2005.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. Procedural Background</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Also in 2005, two former RCG employees, Julie Williams and Dr. John
Martinez ("the relators"), filed a <i>qui tarn</i> action under the False Claims
Act, 31 U.S.C. &sect; 3729-33, against RCG and RCGSC in the United States
District Court for the Eastern District of Missouri. The relators contended
that RCGSC "is not a legitimate and independent durable medical equipment
supply company," but a "billing conduit" used to unlawfully inflate Medicare
reimbursements. Two years later, the United States intervened in the case,
and the relators' claim was voluntarily dismissed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The United States alleged that the defendants violated the False Claims
Act by submitting claims while knowing that RCGSC was a sham corporation
created for the sole purpose of increasing Medicare reimbursements (Count
One); while knowing that RCGSC was not in compliance with Medicare rules and
regulations
<span CLASS="page_no" data-cite="696 f 3d 524" data-cite-type="PrimaryFederalReporter" data-cite-pageno="524" data-primary-citation="696 F.3d 518">[*524]</span> 
(Count Two); while knowing that RCGSC was misleading patients over their
right to choose between Method I and Method II reimbursements (Count Three);
and for facility support charges for services rendered to home dialysis
patients who had selected Method II reimbursements (Count Four). The United
States also sought recovery under common law theories of payment by mistake
(Count Five) and unjust enrichment (Count Six). The district court denied
the defendants' affirmative defenses of estoppel, waiver, and laches, noting
that the government does not "waive a defendant's liability for false claims
simply due to the government's knowledge of the circumstances." The
defendants thereafter moved to transfer the case to the Middle District of
Tennessee in the interests of justice, which was granted.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. The Alexander letter</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During discovery, the defendants sought evidence related to whether
Medicare/Centers <span CLASS="page_no" data-cite="2012 bl 261568 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> for Medicare and Medicaid Services (CMS) was aware of the
RCG/RCGSC relationship. As part of this effort, they requested evidence
related to CMS's consideration of Alexander's October 1998 letter to
Richter. In September 2008, the United States denied that it was in
possession of the letter. Richter also testified that the conversation
described in the letter never occurred, and that he was positive that he had
never received the letter.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In April 2009, a few weeks before the deadline for completion of all
discovery, the United States informed defense counsel that responsive
documents may have been inadvertently archived. Leila Carp, an attorney in
the Office of General Counsel of the United States Department of Health and
Human Services (HHS), had been asked by an HHS employee for assistance in
drafting a response to the Alexander letter. Carp did so, and then archived
the requested materials. The United States sent a letter explaining this to
defense counsel and included a copy of the Alexander letter with a
handwritten annotation in the corner reading, "assign to: Gene," as well as
a privilege log indicating that a "[d]raft letter to Dawn Alexander
discussing Method II" was being withheld for "DP, AC." "DP" and "AC" stand
for "deliberative process" and "attorney-client" privilege, respectively.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants moved the district court to compel the United States to
turn over the documents, as well as to provide unredacted versions of
related documents that had already been provided. The defendants also moved
the district court to impose sanctions on the United States for maintaining
"for more than two years that Richter (a) did not recall having the
conversation with Alexander and (b) did not receive the confirming letter
sent by [Alexander]." The United States opposed the motion, contending that
it "made good faith efforts to satisfy [its] discovery obligations[,] did
not make false discovery responses, offer false deposition testimony, or
coerce a partial waiver of the attorney client privilege." The district
court denied both the motion to compel and the motion for sanctions without
explanation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. The Initial Grant of Summary Judgment</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Immediately prior to the case being transferred, the United States moved
for partial summary judgment, but only as to the issues of falsity and
materiality, two of the four elements of Count One (violating the False
Claims Act by submitting claims to Medicare while knowing that RCGSC was a
sham corporation), as well as liability under Count Six (the unjust
enrichment claim). The United States noted that granting the motion would
"streamline and greatly simplify the issues for trial, focusing
<span CLASS="page_no" data-cite="696 f 3d 525" data-cite-type="PrimaryFederalReporter" data-cite-pageno="525" data-primary-citation="696 F.3d 518">[*525]</span> 
the fact-finder on the key issues[,] defendants' knowledge under the FCA and
the scope of any remedy to be awarded under Counts I and VI." The defendants
also filed a motion for summary judgment, but as to all counts.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court granted the government's motion and denied the
defendants' motion ("the March 2010 order"). It noted that the Defendants
acted with "reckless disregard" of relevant Medicare statutes <span CLASS="page_no" data-cite="2012 bl 261568 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> and
regulations, and that in doing so they were unjustly enriched. It then
adopted the United States's damages calculation and noted that it is
"unnecessary to consider the United States'[s] other claims."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants promptly appealed this and eleven other orders to this
Court. The United States sought an indicative ruling from the district court
clarifying, <i>inter alia</i>, whether the partial grant of summary judgment was in
fact a total grant of summary judgment. In its ruling ("the June 2010
order"), the district court made clear that, "based on undisputed facts," it
decided the issue of knowledge (an element of a False Claims Act
allegation), even though the United States only sought summary judgment as
to the issues of materiality and falsity in Count One. And, although the
defendants had not discussed the issue of knowledge in their response to the
United States's motion for summary judgment, the district court noted that
by virtue of their own motion for summary judgment, the defendants "were on
actual notice to come forth with all of their proof." The district court
also made clear that it "would have also granted summary judgment on the
United States's claims in Counts 2 through 5."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This Court denied the defendants' appeal because "the March [2010] order
does not resolve all claims pending in this action, [so] the order is not
appealable as a final order. . . ." <i>United States ex rel. Williams et al. v.</i>
<i>Renal Care Group et al</i>, No. 10-5327/5746 (6th Cir. Sept. 23, 2010). On
remand, the United States requested an award under Count One of $105,898,930
and a grant of summary judgment as to Counts Two through Five. The district
court granted that motion, but also reconsidered its previous damages
calculations ("the May 2011" order). It clarified that "the United States
seeks a judgment on the merits of all of its claims, but only an award of
damages and penalties on its FCA claims in count one of its amended
complaint." The award included $12,957,864 on Count One, which, because it
was a False Claims Act liability, was trebled for a total damage award of
$38,873,592. Additionally, the district court granted statutory penalties of
$43,769,000 based on its determination that the defendants "admitted 3979
patients to whom equipment was provided under the Method II program and the
$11,000 statutory penalty standard" under the False Claims Act. Thus, the
total award equaled $82,642,592.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The United States notified the district court that it did not intend to
seek a higher amount of damages. The district court then issued another
indicative ruling, noting that the March 2010 order "was a final judgment
awarding damages on count I," and the May 2011 order "awarded the United
States judgment against the Defendants on the remaining counts II-VI and
awarded damages." The defendants timely appealed fourteen of the district
court's orders to this Court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  II. ANALYSIS
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A. Discovery Disputes</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants appeal two of the district court's discovery rulings.
First, they contend that the district court erred in failing to issue
sanctions against the
<span CLASS="page_no" data-cite="696 f 3d 526" data-cite-type="PrimaryFederalReporter" data-cite-pageno="526" data-primary-citation="696 F.3d 518">[*526]</span> 
United States over the Alexander letter/<span CLASS="page_no" data-cite="2012 bl 261568 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> Richter response. Second, they
contend that the documents protected by the deliberative process privilege
should have been produced. We review the district court's rulings on these
discovery disputes for an abuse of discretion. <i>Bentkowski v. Scene Magazine</i>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1FAI6U003?jcsearch=637%20f%203d%20689&amp;summary=yes#jcite">637 F.3d 689</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1FAI6U003?jcsearch=637%20f%203d%20689&amp;summary=yes#jcite">696</a> (6th Cir.2011). "[A]n abuse of discretion occurs when (1)
the district court's decision is based on an erroneous conclusion of law,
(2) the district court's findings are clearly erroneous, or (3) the district
court's decision is clearly unreasonable, arbitrary or fanciful." <i>Tisdale v.</i>
<i>Fed. Express Corp.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X12HRDA003?jcsearch=415%20f%203d%20516&amp;summary=yes#jcite">415 F.3d 516</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X12HRDA003?jcsearch=415%20f%203d%20516&amp;summary=yes#jcite">525</a> (6th Cir.2005) (alterations and
quotations omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. The Alexander letter</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants' motion for sanctions had been premised on a number of
issues surrounding the Alexander letter and CMS officials' response to it.
These included the filing of interrogatories and document request responses
that contained false information, as well as the testimony of Richter, who
stated under oath that he was positive that the exchange with Alexander had
never taken place. In their motion, the defendants requested the dismissal
of the entire action as sanction, but did not indicate whether the sanctions
should be awarded pursuant to any particular Federal Rule of Civil Procedure
or under the district court's inherent authority. The district court denied
the defendants'. motion for sanctions without discussion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Factors to consider in determining whether the district court abused its
discretion in failing to award sanctions include "prejudice resulting from
the discovery abuse, whether the noncooperating party was warned that
violations would result in sanctions, and whether the court considered less
drastic sanctions." <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X12HRDA003?jcsearch=415%20F.3d%20516&amp;summary=yes#jcite">Id</a>.</i> Two of the three factors outlined in <i>Tis-dale</i> are at
issue here and weigh in the defendants' favor. First, Richter's false
testimony and the United States's late turnover of the Alexander letter
prejudiced the defendants' ability to meaningfully depose Richter, which
would have assisted in their efforts to prove that they were not in reckless
disregard of the truth of their requests for payment. Second, although the
defendants requested particularly strident sanctions &mdash; the dismissal of the
complaint with prejudice &mdash; they also requested the "intermediate, interim
relief of "compelling Richter to appear for re-deposition at the
government's expense" and "precluding [the United States] from enlarging
upon the waiver of Defendants' privileges." Although the United States
contends that no prejudice resulted because "the alleged conversation with
Richter was not even the primary basis for the lawyers' advice to [the
defendants]," such a position is far too reliant on questionable inferences
drawn from out-of-context statements by Alexander.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have previously remanded close questions regarding a motion for
sanctions if the district court's denial of sanctions lacks explanation,
<i>Moross Ltd. P'ship v. Fleckenstein Capital, Inc.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X15SI22003?jcsearch=466%20f%203d%20508&amp;summary=yes#jcite">466 F.3d 508</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X15SI22003?jcsearch=466%20f%203d%20508&amp;summary=yes#jcite">519-20</a> (6th
Cir.2006), and do so here. This issue, of course, may become moot should the
defendants not seek to depose Richter again; <span CLASS="page_no" data-cite="2012 bl 261568 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> assuming otherwise, their
request to do so should be granted.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. Documents protected by deliberative process</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants requested documents related to CMS's interpretation of the
relevant Medicare provisions and its knowledge of industry practice. The
United States refused, submitting instead a privilege log showing that the
documents were protected by the deliberative process
<span CLASS="page_no" data-cite="696 f 3d 527" data-cite-type="PrimaryFederalReporter" data-cite-pageno="527" data-primary-citation="696 F.3d 518">[*527]</span> 
privilege. The district court denied the defendants' motion to compel the
production of 323 documents, stating that "the materials are both
predecisional and deliberative" and that "[i]n the absence of a showing that
the privilege is claimed in error or in bad faith, no <i>in camera</i> review is
warranted."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The deliberative process privilege, a carve-out of the Freedom of
Information Act (FOIA), <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEGOVE003?jcsearch=5%20usc%20552&amp;summary=yes#jcite">5 U.S.C. &sect; 552</a>, aims to protect documents that are
both "predecisional" and "deliberative." <i>Norwood v. FAA</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X3TTSF?jcsearch=993%20f%202d%20570&amp;summary=yes#jcite">993 F.2d 570</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X3TTSF?jcsearch=993%20f%202d%20570&amp;summary=yes#jcite">576</a>
(6th Cir.1993). "A document is predecisional when it is received by the
decisionmaker on the subject of the decision prior to the time the decision
is made, and deliberative when it reflects the give-and-take of the
consultative process." <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X3TTSF?jcsearch=993%20F.2d%20570&amp;summary=yes#jcite">Id</a>.</i> (quotation marks and alterations omitted). The
privilege extends when "the disclosure of materials would expose an agency's
decisionmaking process in such a way as to discourage candid discussion
within the agency and thereby undermine the agency's ability to perform its
functions." <i></i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X3TTSF?jcsearch=993%20F.2d%20570&amp;summary=yes#jcite">Id. at 577</a> (quotation marks omitted). Purely factual and
investigative matters that are severable without compromising the
confidentiality of other documents do not enjoy the privilege. <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X3TTSF?jcsearch=993%20F.2d%20570&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have previously held that the district court must be aware of "how each
document fits into the deliberative process" and whether it is an "essential
element of that process. . . ." <i>Parke, Davis &amp; Co. v. Calif ano</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XABEL1?jcsearch=623%20f%202d%201&amp;summary=yes#jcite">623 F.2d 1</a>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XABEL1?jcsearch=623%20f%202d%201&amp;summary=yes#jcite">6</a> (6th Cir.1980). Given that FOIA encourages complete disclosure, the
privilege may only be invoked with specificity and "detailed explanations,"
and the burden lies with the agency to prove that disclosure would create a
chilling effect. <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XABEL1?jcsearch=623%20F.2d%201&amp;summary=yes#jcite">Id</a>.</i> In camera review may be undertaken by the district
court after consideration of judicial economy, agency bad faith, strong
public interest, and the parties' wishes. <i>Rugiero v. U.S. Dep't of Justice</i>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X510OO?jcsearch=257%20f%203d%20534&amp;summary=yes#jcite">257 F.3d 534</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X510OO?jcsearch=257%20f%203d%20534&amp;summary=yes#jcite">543-44</a> (6th Cir.2001). "This circuit, however, encourages use
of <i>in camera</i> review sparingly, when no other procedure allows review of the
agency's response to a FOIA request." <i></i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X510OO?jcsearch=257%20F.3d%20534&amp;summary=yes#jcite">Id. at 544</a>. One such alternative
procedure is a detailed affidavit, which is entitled to a presumption of
good faith. <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X510OO?jcsearch=257%20F.3d%20534&amp;summary=yes#jcite">Id</a>.</i> The affidavit is sufficient if it describes "the content of
the material withheld and adequately states its grounds for nondisclosure,
and if those grounds are reasonable and consistent with the applicable law.
. . ." <i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X510OO?jcsearch=257%20F.3d%20534&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The United States provided an eight-paragraph listing of the documents
contained in the privilege log, as well as declarations and testimony from
government officials employed by the Office of Inspector General. The
affiants do not discuss each of the 323 documents individually, but place
them in categories, and then discuss why each category <span CLASS="page_no" data-cite="2012 bl 261568 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> is covered by the
deliberative process privilege. Total materials submitted in defense of the
privilege's assertion include more than sixty pages of deposition testimony,
and thirty pages of affiant declarations. The materials covered solely by
the deliberative process privilege (and not also covered by attorney work
product or other privileges) include HHS e-mails on agency comments and
clearance of OIG draft reports, e-mails on a draft of an agency's report,
e-mails comprising suggestions on a draft OIG report, and correspondence on
a draft ESRD publication. The affiants' declarations, which carry a
presumption of good faith, explain the nature of the documents, how
disclosure would affect the agency process, and are not blanket assertions.
The district court did not abuse its discretion in denying the defendants'
motion to compel.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. Count One</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The complaint against the defendants centers around RCGSC's requests
<span CLASS="page_no" data-cite="696 f 3d 528" data-cite-type="PrimaryFederalReporter" data-cite-pageno="528" data-primary-citation="696 F.3d 518">[*528]</span> 
for Method II reimbursements. A number of other actions were also alleged to
be false claims violations, though there is little in the way of factual
development that provides us with a basis to affirm or reverse the district
court's decisions on those claims. The United States made clear to the
district court that it would not seek damages under those ancillary counts
if the defendants were liable under Count One, and the district court's
damages calculations were based entirely on the conduct alleged under Count
One of the complaint.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For a defendant to be liable under the False Claims Act, it must knowingly
present, or cause to be presented, "a false or fraudulent claim for payment
or approval." <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)(A)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1)(A). Liability does not require proof of
specific intent to defraud, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(b)(1)(B)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(B), but does require that
the falsity be material to the claim, <i>United States ex rel. A + Homecare,</i>
<i>Inc. v. Medshares Mgmt. Grp. Inc.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XVOC73?jcsearch=400%20f%203d%20428&amp;summary=yes#jcite">400 F.3d 428</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XVOC73?jcsearch=400%20f%203d%20428&amp;summary=yes#jcite">444</a> (6th Cir.2005). The
defendants put forth two distinct bases for their position that their
actions do not constitute False Claims Act violations. First, they contend
that the United States's interpretation of the federal laws and regulations
at issue is erroneous, and that the submitted reimbursements were not in
fact false. Second, they contend that even if the claims technically were
false, the statutory guidance is ambiguous, such that they did not act with
the requisite knowledge to be held liable under the False Claims Act. We
address both in turn.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>1. Falsity</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court's March 2010 order provides minimal insight into
whether a separately incorporated entity with its own Medicare supplier
number was an entity eligible for Method II reimbursements. After conducting
a lengthy inquiry into the origins of Medicare's regulations for Method II
reimbursements, the district court concluded that "RCG's creation, operation
and control of RCGSC was to receive the higher Method II payments." The
district court did not, however, articulate any reason as to why this was
inherently improper. Indeed, it stated that Congress passed relevant
Medicare regulations that would reimburse "legitimate supply companies," <span CLASS="page_no" data-cite="2012 bl 261568 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> but
the statute at issue in that discussion, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(1)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(1)(B),
highlights only that home dialysis supply companies are eligible for
Medicare reimbursement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The United States's argument boils down to this: dialysis facilities may
not seek Method II reimbursements, and RCGSC was an alter ego of RCG, a
dialysis facility; ergo, RCGSC improperly sought Method II reimbursements.
The flaw in the argument, however, is that it misunderstands the contours of
our alterego jurisprudence. As became clear during oral argument, the United
States focuses, somewhat obsessively, on evidence demonstrating that RCG
sought Method II reimbursements for the sole purpose of increasing its
profit margins.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Why a business ought to be punished solely for seeking to maximize profits
escapes us. The corporate form need not be disregarded when its adoption was
meant to "secure its advantages and where no violence to the legislative
purpose is done by treating the corporate entity as a separate legal
person." <i>Schenley Distillers Corp. v. United States</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X5C0UG?jcsearch=326%20us%20432&amp;summary=yes#jcite">326 U.S. 432</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X5C0UG?jcsearch=326%20us%20432&amp;summary=yes#jcite">437</a>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X5C0UG?jcsearch=66%20supreme%20court%20247&amp;summary=yes#jcite">66 S.Ct. 247</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X5C0UG?jcsearch=90%20l%20ed%20181&amp;summary=yes#jcite">90 L.Ed. 181</a> (1946). The United States does not, however,
identify any clear legislative purpose emanating from either the text of
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20usc%201395rr&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a> or from the legislative materials predating its passage.
Its failure to do so is fatal for its assertion of the alterego doctrine,
for we are similarly unable to
<span CLASS="page_no" data-cite="696 f 3d 529" data-cite-type="PrimaryFederalReporter" data-cite-pageno="529" data-primary-citation="696 F.3d 518">[*529]</span> 
divine any such purpose from the scheme transgressed by the defendants'
acts.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Courts have not addressed why Congress adopted a bifurcated reimbursement
model for home dialysis ESRD suppliers. In the statutory text, Congress made
clear that it wanted to encourage ESRD patients to have dialysis at home in
order to reduce costs for the patient and Medicare.
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(3)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(3)(B) (requesting the HHS Secretary to promulgate ESRD
reimbursement methods which will "effectively encourage[] the efficient
delivery of dialysis services and provide incentives for the increased use
of home dialysis"); <i>see also</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=75%20Fed.%20Reg.%2049&amp;summary=yes#jcite">75 Fed. Reg. 49</a>, 030-01, 49, 062 (Aug. 12, 2010)
("[T]here remain very good reasons to develop and expand home [peritoneal
dialysis] programs. For example, PD treatment costs considerably less than
comparable in-facility treatments."). But Method I and Method II both apply
to home dialysis suppliers &mdash; the only difference is that Method I suppliers
also offer support services. Based on the structure of the statute, Congress
seems to have differentiated between Method I and Method II for two reasons:
first, to ensure that home dialysis patients could engage in cost
comparisons for their supplies and purchase dialysis supplies and equipment
from a broader range of providers; and second, to make clear that Method II
suppliers would have to have some type of written agreement with their
patients, ensuring that support services would be offered if necessary.
<i>See</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=57%20federal%20register%2054&amp;summary=yes#jcite">57 Fed. Reg. 54</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=57%20federal%20register%2054&amp;summary=yes#jcite">179</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=57%20federal%20register%2054&amp;summary=yes#jcite">54</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=57%20federal%20register%2054&amp;summary=yes#jcite">179</a> (Nov. 17, 1992) ("Method II is an
alternative to Method I which allows the beneficiary to make his or her own
arrangements for supplies and equipment."). Neither of these purposes are
violated by allowing RCGSC to receive Method II reimbursements.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The relevant statute, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XEJAMG003?jcsearch=42%20U.S.C.%20%201395rr(b)(4)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(4)(B) precludes Method II
payments to dialysis <span CLASS="page_no" data-cite="2012 bl 261568 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> suppliers that are also "renal dialysis facilit[ies],"
and <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/XDLUMC003?jcsearch=42%20cfr%20400%20202&amp;summary=yes#jcite">42 C.F.R. &sect; 400.202</a> defines a "supplier" as "an entity other than a
provider, that furnishes health care services under Medicare." Other federal
regulations provide insight into what an "entity" is, which, in many ways,
is the key question &mdash; whether RCGSC is an "entity" for purposes of
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20400%20202&amp;summary=yes#jcite">42 C.F.R. &sect; 400.202</a>. <i>See</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%201001%201001&amp;summary=yes#jcite">42 C.F.R. &sect; 1001.1001</a> (allowing the Office of
Inspector General to exclude entities from participation if certain
individuals have a direct or indirect ownership of five or more percent in
the entity); <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%2073%207&amp;summary=yes#jcite">42 C.F.R. &sect; 73.7</a> (articulating when an entity &mdash; there, a
private institution of higher education &mdash; is controlled by another);
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20420%20206&amp;summary=yes#jcite">42 C.F.R. &sect; 420.206</a> (discussing what information about an entity's ownership
structure needs to be disclosed). Additionally, federal regulations
routinely address the common ownership/control inquiry.
<i>See</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20417%20484&amp;summary=yes#jcite">42 C.F.R. &sect; 417.484</a> (defining a "related entity" as "any entity that is
related to the [party] by common ownership or control. . . .");
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20433%2052&amp;summary=yes#jcite">42 C.F.R. &sect; 433.52</a> (noting that an "entity related to a health care
provider" is, <i>inter alia</i>, "an organization, association, corporation, or
partnership formed by or on behalf of a health care provider");
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20423%20501&amp;summary=yes#jcite">42 C.F.R. &sect; 423.501</a> ("Related entity means any entity that is related . . .
by common ownership or control. . . ."). Although not dispositive, these
regulations suggest that an organization can be controlled by another and
yet still be considered an "entity" for purposes of Method II reimbursement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  All of this points to the conclusion that the structure of RCG and RCGSC
is not obviously inconsistent with Congress's goals for the payment scheme.
As the district court "noted, "[i]f the Medicare statutes or regulations
were unclear and ambiguous, the Defendants' proof on then-contacts and
disclosures would be probative on the United States's FCA claim.".
<span CLASS="page_no" data-cite="696 f 3d 530" data-cite-type="PrimaryFederalReporter" data-cite-pageno="530" data-primary-citation="696 F.3d 518">[*530]</span> 
We agree, and therefore must next answer the question of whether the
defendants' actions constituted reckless disregard of the relevant federal
statutes and regulations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>2. Knowledge</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants contend that they did not knowingly submit false claims;
that is, that they did not know, at the time that the claims were submitted,
that RCGSC was not a valid entity for purposes of receiving Method II
reimbursements. The United States's original motion for summary judgment was
limited to two of the four elements of a False Claims Act violation &mdash;
falsity and materiality. The defendants moved for total summary judgment,
but the theory underlying that motion was specific to the element of
falsity. The district court, however, answered the question of knowledge as
well, noting that the Defendants acted with "reckless disregard" of relevant
Medicare statutes and regulations. This determination is reviewed de novo.
<i>See United States ex rel. Schell v. Battle Creek Health Sys.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=419%20f%203d%20535&amp;summary=yes#jcite">419 F.3d 535</a>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=419%20f%203d%20535&amp;summary=yes#jcite">537-38</a> (6th Cir.2005).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For a defendant to be liable under the False Claims Act, it must have
acted knowingly; such knowledge can be actual, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(i),
or constructive, either because it acted in deliberate ignorance of the
truth, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(ii), or in reckless disregard of it,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(iii). The "reckless disregard" prong was enacted
in a 1986 amendment to the False Claims Act, and what appears to be the only
congressional <span CLASS="page_no" data-cite="2012 bl 261568 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> report accompanying that bill states that the obligation is
"to make such inquiry as would be reasonable and prudent to conduct under
the circumstances. . . . Only those who act in `gross negligence' of this
duty will be found liable under the False Claims Act." S. Rep. 99-345, at
20, 1986 U.S.C.C.A.N. 5266, 5285. The provision is meant to target that
defendant who has "buried his head in the sand" and failed to make some
inquiry into the claim's validity. <i>Id.</i> at 21, 1986 U.S.C.C.A.N. at 5286. The
inquiry, however, need only be "`reasonable and prudent under the
circumstances,' which clearly recognizes a <i>limited duty to inquire as</i>
<i>opposed to a burdensome obligation." Id.</i> (emphasis added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>United States ex rel. Compton v. Midwest Specialties, Inc.</i>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=142%20f%203d%20296&amp;summary=yes#jcite">142 F.3d 296</a> (6th Cir.1998), the defendant was accused of violating the
False Claims Act by failing to comply with a testing requirement for Army
jeep brake shoes that it supplied. This Court affirmed the district court's
grant of summary judgment in favor of the United States, noting that the
defendant had a reckless disregard for the falsity of its claims for
payment:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      Midwest's president testified in his deposition that he knew the
    plug-welded brake shoes were subject to the testing requirement.
    Despite knowledge of this requirement, Midwest did not test the
    brake shoes as required by the contracts. Midwest then submitted
    claims for payment to the government attesting that the brake-shoe
    kits conformed to contract requirements. This is sufficient to
    constitute "reckless disregard" of the truth of its representations
    as to contract compliance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> at 304. No similar allegations are made here by the United States &mdash;
there is no claim that RCG or RCGSC officials knew that submitting Method II
claims by a wholly-owned subsidiary ran afoul of the Medicare regulations.
Rather, the United States contends that the regulations were clear that
wholly-owned subsidiaries were ineligible, and that reliance on statements
by government officials could not surmount such clear direction.
</p></div>
<span CLASS="page_no" data-cite="696 f 3d 531" data-cite-type="PrimaryFederalReporter" data-cite-pageno="531" data-primary-citation="696 F.3d 518">[*531]</span> <div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Other circuits have had the opportunity to define the exact contours of
the "reckless disregard" standard. <i>See United States ex rel. K &amp; R Ltd.</i>
<i>P'ship v. Mass. Hous. Fin. Agency</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=530%20f%203d%20980&amp;summary=yes#jcite">530 F.3d 980</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=530%20f%203d%20980&amp;summary=yes#jcite">983</a> (D.C.Cir.2008)
("Reckless disregard under the FCA is an extreme version of ordinary
negligence.") (quotation marks omitted); <i>United States ex rel. Burlbaw v.</i>
<i>Orenduff</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=548%20f%203d%20931&amp;summary=yes#jcite">548 F.3d 931</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=548%20f%203d%20931&amp;summary=yes#jcite">945</a> n. 12 (10th Cir.2008) (equating "reckless
disregard" with "an aggravated form of gross negligence"); <i>see also United</i>
<i>States ex rel. Ervin &amp; Assocs., Inc. v. Hamilton Sec. Grp., Inc.</i>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=370%20f%20supp%202d%2018&amp;summary=yes#jcite">370 F.Supp.2d 18</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=370%20f%20supp%202d%2018&amp;summary=yes#jcite">41</a> (D.D.C.2005) ("Reckless disregard, as used in the False
Claims Act, lies on a continuum between gross negligence and intentional
harm.") (quotation marks and emphasis omitted). Given that 1) the defendants
sought legal counsel on this issue; 2) defendants' legal counsel sought
clarification on the rules from CMS officials; 3) the Alexander letter
referenced a positive conversation with Richter, and her notes and billing
records reflect as such; 4) the defendants were aware of large dialysis
providers that had wholly-owned subsidiaries filing for Method' II
reimbursements; <span CLASS="page_no" data-cite="2012 bl 261568 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> 5) industry publications openly encouraged the use of Method
II reimbursements to increase profit; 6) RCGSC was a separately incorporated
entity with its own Medicare supplier number; and 7) CMS and OIG knew of
RCGSC's ownership structure, the defendants were not in reckless disregard
of the truth or falsity of their claims. Rather, they consistently sought
clarification on the issue, followed industry practice in trying to sort
through ambiguous regulations, and were forthright with government officials
over RCGSC's structure. To deem such behavior "reckless disregard" of
controlling statutes and regulations imposes a burden on government
contractors far higher than what Congress intended when it passed
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(iii).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants did not act with reckless disregard of the alleged falsity
of their submissions to Medicare. And given that there is no evidence in the
record that they acted with actual knowledge (in violation of
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(i)), or in deliberate ignorance of the truth (in
violation of <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(b)(1)(A)(ii)), they are therefore not liable
under Count One of the complaint for False Claims Act liability. As such, we
need not address their claim of error regarding the district court's damages
calculations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>C. Counts Two Through Six</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court granted summary judgment, without explanation, as to
the remainder of the United States's substantive claims against the
defendants. There is little in the record for us to review as to those
counts, and what little we can find must be gleaned from the vague language
in the initial complaint. As such, we are unable to review substantively the
district court's judgments as to the majority of those claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The one exception to this, however, is Count Two, which' alleges that the
defendants violated the False Claims Act by "submitting false and fraudulent
claims . . . knowing full well that RCGSC was merely a billing conduit
[that] was not in compliance with the durable medical equipment supplier
standards set forth at <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20usc%201395m&amp;summary=yes#jcite">42 U.S.C. &sect; 1395m</a> and 42 C.F.R. &sect; 424.57." For a
dialysis supplier like RCGSC to receive reimbursement, it "must meet and
must certify in its application for billing privileges that it meets and
will continue to meet" certain standards, including honoring warranties,
filling orders from its own inventory or via contract, and maintaining an
appropriate place of business. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20424%2057&amp;summary=yes#jcite">42 C.F.R. &sect; 424.57</a>(c). The provision also has
an independent
<span CLASS="page_no" data-cite="696 f 3d 532" data-cite-type="PrimaryFederalReporter" data-cite-pageno="532" data-primary-citation="696 F.3d 518">[*532]</span> 
sanction. <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20cfr%20424%2057&amp;summary=yes#jcite">42 C.F.R. &sect; 424.57</a>(d) ("CMS will revoke a supplier's billing
privileges if it is found not to meet the [applicable standards]."). The
defendants contend that violations of such conditions do not render a claim
materially false, and thus may not subject them to False Claims Act
liability.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The defendants are correct, irrespective of whether they in fact violated
the regulations. The False Claims Act is not a vehicle to police technical
compliance with complex federal regulations. <i>See, e.g., United States ex</i>
<i>rel. Wilkins v. United Health Grp., Inc.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=659%20f%203d%20295&amp;summary=yes#jcite">659 F.3d 295</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=659%20f%203d%20295&amp;summary=yes#jcite">308</a> (3d Cir.2011)
("[An allegation] that appellees violated the regulations do[es] not state a
plausible claim for relief under the FCA inasmuch as the Government's
payments <span CLASS="page_no" data-cite="2012 bl 261568 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> of appellees' Medicare claims were not conditioned on their
compliance with the marketing regulations."); <i>United States ex rel. Gross v.</i>
<i>AIDS Research Alliance-Chicago</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=415%20f%203d%20601&amp;summary=yes#jcite">415 F.3d 601</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=415%20f%203d%20601&amp;summary=yes#jcite">604</a> (7th Cir.2005) ("An FCA
claim premised upon an alleged false certification of compliance . . . also
requires that the certification of compliance be a condition of or
prerequisite to government payment.") (alteration omitted); <i>United States v.</i>
<i>Southland Mgmt. Corp.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=326%20f%203d%20669&amp;summary=yes#jcite">326 F.3d 669</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=326%20f%203d%20669&amp;summary=yes#jcite">684</a> (5th Cir.2003) ("[T]he punitive
treble damages and penalties afforded by civil FCA actions are not
interchangeable with remedies for ordinary breaches of contract."); <i>United</i>
<i>States ex rel. Jamison v. McKesson Corp.</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=784%20f%20supp%202d%20664&amp;summary=yes#jcite">784 F.Supp.2d 664</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=784%20f%20supp%202d%20664&amp;summary=yes#jcite">679</a>
(N.D.Miss.2011) ("Defendants cannot be held to have submitted false claims
where the governmental agency charged with compliance certified that [the
defendant] was in compliance with the regulations."); <i>Hansen v. Freedom</i>
<i>Mobility, Inc.</i>, No. 5:08-CV-131, 2009 WL 3784958, at *2 (W.D.N.C. Nov. 10,
2009) ("Failure to comply with regulations regarding billing or insurance
might result in removal of Medicare billing privileges by the government,
but would not establish any tort or negligence liability here.") (citation
omitted); <i>United States ex rel. Landers v. Baptist Mem'l Health Care Corp.</i>,
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=525%20f%20supp%202d%20972&amp;summary=yes#jcite">525 F.Supp.2d 972</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=525%20f%20supp%202d%20972&amp;summary=yes#jcite">978-79</a> (W.D.Tenn. 2007) (precluding False Claims Act
liability for violations of conditions of participation, which are "the
requirements providers must meet to participate in the Medicare program,"
because the HCFA/CMS forms do not expressly or impliedly condition payment
upon compliance with participation conditions) (citation and alteration
omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The regulations set forth in the United States's complaint are conditions
of participation, the violation of which do not lead to False Claims Act
liability. Consequently, the district court erred in granting summary
judgment in favor of the United States on this claim, and the defendants'
motion for summary judgment as to Count Two is granted. There is
insufficient evidence in the record, however, for us to conduct a similar
analysis as to the remaining counts, and we therefore reverse and remand
those district court judgments for further proceedings that are consistent
with this opinion, if necessary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>D. Reassignment</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, the defendants ask that the case be reassigned to another
district judge if a remand is necessary. To determine whether reassignment
is necessary, the following factors are considered:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      (1) whether the original judge would reasonably be expected to
    have substantial difficulty in putting out of his or her mind
    previously expressed views or findings; (2) whether reassignment is
    advisable to preserve the appearance of justice; and (3) whether
    reassignment would entail waste and duplication out of
<span CLASS="page_no" data-cite="696 f 3d 533" data-cite-type="PrimaryFederalReporter" data-cite-pageno="533" data-primary-citation="696 F.3d 518">[*533]</span> 
    proportion to any gain in preserving the appearance of fairness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Solomon v. United States</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=467%20f%203d%20928&amp;summary=yes#jcite">467 F.3d 928</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=467%20f%203d%20928&amp;summary=yes#jcite">935</a> (6th Cir.2006). Reassignment "is
an extraordinary power and should be rarely invoked." <i>Id.</i> (quotation marks
omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There is no question that this is a case with a "complex factual record."
<i>Hamad v. Woodcrest Condo. Ass'n</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=328%20f%203d%20224&amp;summary=yes#jcite">328 F.3d 224</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=328%20f%203d%20224&amp;summary=yes#jcite">239</a> (6th Cir.2003) (declining
reassignment based, in part, on the "extensive <span CLASS="page_no" data-cite="2012 bl 261568 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> joint appendix and hundreds
of pages of briefs"). And, unlike our decisions in other cases supporting
reassignment, there are no comments made by the district court here that
would undermine the appearance of justice. <i>See, e.g., United States v.</i>
<i>Gapinski</i><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=422%20f%20appx%20513&amp;summary=yes#jcite">422 Fed.Appx. 513</a>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=422%20f%20appx%20513&amp;summary=yes#jcite">521-22</a> (6th Cir.2011) (listing a series of
statements by the district court that warranted reassignment). . False
Claims Act cases are exceedingly fact-determinative and technical, and
mistakes of law should not warrant the use of a tool that should be wielded
with "the greatest reluctance," <i>Solomon</i>, <a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=467%20f%203d%20928&amp;summary=yes#jcite">467 F.3d at 935</a>. The defendants'
request for reassignment is therefore denied.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  III. CONCLUSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court's judgments as to Counts One and Two are REVERSED, and
the defendants' motion for summary judgment as to those counts is GRANTED.
The district court's judgments as to all remaining counts are REVERSED and
REMANDED for further proceedings consistent with this opinion, but the
defendants' motion for reassignment is DENIED.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  ROSEN, Chief District Judge, concurring.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I concur with the majority's decision to reverse the district court's
grant of summary judgment in favor of the plaintiff United States of America
on Counts One and Two of the complaint, and to instead award summary
judgment in the defendants' favor on these claims. As the majority observes,
the Government's claim in Count One rests upon the proposition that
defendant Renal Care Group Supply Company ("RCGSC") did not qualify as a
separate "entity" from its parent corporation, defendant Renal Care Group,
Inc. ("RCG"), and the numerous subsidiaries of RCG that operated renal
dialysis facilities, so that RCGSC therefore was ineligible for so-called
"Method II" reimbursement under the pertinent Medicare statutory provisions
and regulations. I write separately to emphasize that the governing
statutory and regulatory scheme offers virtually no signposts for resolving
this key question of RCGSC's eligibility for Method II payments, and to
explain why, in my view, this uncertainty alone leads fairly directly to the
conclusion that the evidence marshaled by the Government fails as a matter
of law to establish the "knowledge" element of its Count One claim under the
False Claims Act ("FCA"), 31 U.S.C. &sect; 3729-33.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As is evident from the majority opinion, it is no simple task in this case
to determine whether the claims submitted' by RCGSC for Method II
reimbursement truly qualified as "false" within the meaning of the FCA. In
asserting that these claims were indeed false, the Government relies
principally upon statutory language that authorizes Method II payments to a
"supplier of home dialysis supplies and equipment" only if this supplier "is
not a provider of services [or] a renal dialysis facility."
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20usc%201395rr&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(1)(C). As explained by the majority, the Government
maintains that RCGSC failed' this test for Method II reimbursement because
it was a mere alter ego of its parent company, RCG, which in turn had a
number of other subsidiaries that operated renal dialysis facilities. The
defendants, in contrast, argue that RCGSC
<span CLASS="page_no" data-cite="696 f 3d 534" data-cite-type="PrimaryFederalReporter" data-cite-pageno="534" data-primary-citation="696 F.3d 518">[*534]</span> 
was a separate legal entity <span CLASS="page_no" data-cite="2012 bl 261568 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> from the RCG subsidiaries that provided renal
dialysis services, and that this supply company therefore was eligible for
Method II payments by virtue of its separate corporate existence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The crux of the parties' dispute, then, is the degree of "separateness"
demanded under the pertinent Medicare statutory provisions and regulations
in order for a supplier to be deemed "not a provider of services [or] a
renal dialysis facility." As the defendants observe, there is no basis in
the Medicare statute or its implementing regulations for concluding that a
Method II supplier must be wholly independent from any service provider or
renal dialysis facility, without any corporate affiliation whatsoever. On
the other hand, there surely must come a point at which a supplier could be
deemed "separate" from a service provider or dialysis facility in only the
most formalistic or technical sense, with one of these two entities being a
mere shell of the other.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Accordingly, to determine whether RCGSC's claims for Method II
reimbursement were false, we must first ascertain where Medicare draws this
line, and then decide whether the defendants crossed it. Yet, upon reviewing
the various Medicare provisions and regulations cited by the parties, I see
no clear answers to these questions, nor even a fixed, determinate set of
criteria that a supplier must meet in order to be considered a separate
"entity" from an affiliated service provider or renal dialysis facility. The
majority evidently shares my reluctance to declare that RCGSC's Method II
claims either were or were not false, as it concludes only that "the
structure of RCG and RCGSC is not obviously inconsistent with Congress's
goals" in creating the Method I/Method II reimbursement scheme. (Majority
Op. at 529.)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Against this backdrop, I agree with the majority that the Government
cannot show that RCGSC's claims for Method II reimbursement reflected a
reckless disregard of the relevant Medicare statutes and regulations. As the
majority observes, it certainly made business sense for RCG and its
subsidiaries to attempt to secure a greater share of the more lucrative
Method II payments, provided that this profit-maximizing goal could be
lawfully achieved. As it commenced this effort, RCG took a number of steps
to ensure that its newly formed subsidiary, RCGSC, was eligible for Method
II reimbursement as a supplier of home dialysis supplies and equipment,
including (i) engaging a law firm to analyze this issue, and (ii) reaching
out to federal "agency officials to obtain their views on the lawfulness of
the parent/subsidiary relationship between RCG and RCGSC. RCG then largely
followed the advice it received through these communications with counsel
and with federal officials, creating RCGSC as a separate entity with its own
Medicare provider number. In addition, RCG took steps to ensure the separate
corporate existence of RCGSC and the RCG subsidiaries that operated renal
dialysis facilities; although parent RCG provided payroll, legal, human
resources, and accounting <span CLASS="page_no" data-cite="2012 bl 261568 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> support for RCGSC's operations, furnished office
space to this subsidiary, and allowed RCGSC to obtain supplies through RCG's
contracts with various manufacturers, the defendants state without
contradiction that there was no similar sharing of office space, employees,
or resources among RCGSC and any of the RCG subsidiaries that provided renal
dialysis services. Finally, the defendants divulged this chosen corporate
organizational scheme to the Government on a number of occasions over the
years, including in Medicare re-enrollment applications and in audits and
inspections,
<span CLASS="page_no" data-cite="696 f 3d 535" data-cite-type="PrimaryFederalReporter" data-cite-pageno="535" data-primary-citation="696 F.3d 518">[*535]</span> 
without ever being advised that this arrangement was problematic.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To be sure, there were a few "storm warnings" along the way that raised
questions about the legality of RCGSC's claims for Method II reimbursement.
Yet, in each such instance, RCG made further inquiries to satisfy itself
that its supplier subsidiary was acting in accordance with the relevant
Medicare statutes and regulations. For instance, when the chief operating
officer of RCG's South Central Region, David Jones, expressed concern in an
October 1998 e-mail that RCG's proposed plan to obtain Method II payments
might be an illegal scheme "simply to increase profits of our Company," the
company did not ignore this warning or sweep it under the rug. Instead,
Jones's message was forwarded to a number of senior company officials, who
in turn continued their exploration, through outside counsel and contacts
with federal officials, into the lawfulness of Method II reimbursement
through a supplier subsidiary. Similarly, when RCG later learned that a
competitor, Gambro Healthcare, was under federal investigation, resulting in
a Gambro subsidiary pleading guilty to health care fraud related to its
Method II billing, company officials reviewed RCGSC's operations to ensure
that RCG's supplier subsidiary was not operating in a similar fashion.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In short, when RCG sought to increase its profits through greater
utilization of Method II reimbursement, it elected to accomplish this
objective by forming a wholly-owned subsidiary, RCGSC. In order for this
supplier to lawfully collect Method II payments, RCG had to ensure that this
newly-formed subsidiary was sufficiently separate and distinct from other
RCG subsidiaries that provided dialysis services, such that RCGSC would not
also be deemed "a provider of services [or] a renal dialysis facility."
<a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/1?citation=42%20usc%201395rr&amp;summary=yes#jcite">42 U.S.C. &sect; 1395rr</a>(b)(1)(C). Although the district court construed the
pertinent Medicare statutes and regulations as clearly prohibiting the
parent/subsidiary arrangement adopted by RCG, my colleagues and I agree,
that the statutory scheme provides little or no guidance as to whether and
how suppliers and service providers may co-exist within the same corporate
family tree. Faced with this unclear and ambiguous statutory scheme, RCG
sought the advice of counsel and federal officials as to whether its plan
for Method II reimbursement was lawful, and it made no secret of the
corporate arrangement it had chosen to pursue Method II payments. <span CLASS="page_no" data-cite="2012 bl 261568 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[**18]</span> Under this
record, I cannot see how the defendants could be found to have acted in
reckless disregard of the Medicare statutes and regulations governing Method
II reimbursement. Because the majority reaches this same conclusion, I join
in its decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> As the defendants observe, the federal criminal charge against
Gambro's subsidiary, REN Supply Corporation, was based on REN's failure to
disclose that Gambro was its parent company. Although RCGSC's initial 1999
application for a Medicare supplier number suffered from a similar defect &mdash;
<i>i.e.</i>, a failure to identify RCG as the parent of this supplier &mdash; RCGSC's
subsequent renewal applications correctly disclosed this parent/subsidiary
relationship, as did other communications with Government officials during
the relevant period.
</p></div>
<!--BBLS DD 1741445857283-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1ILR46003/history">Direct History (10)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1ILR46003/analysis">Case Analysis (6)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1ILR46003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
6
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Reversed, Motion Denied, Motion For Summary Judgment Granted (In Part), Case Remanded</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Health &amp; Medical</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/document/X1Q6LLC966O2">11-05779 (6th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Health Law</div><div class='facetItemLabel'>Privacy &amp; Information Law</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/1c6421174b74ffac9e6c8f5d9a952ae5/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "1c6421174b74ffac9e6c8f5d9a952ae5";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY61582c&previousPageId=&previousActivityInstanceId=ENTITY17599e&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:25:03-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1ILR46003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY17599e&previousPageId=&previousActivityInstanceId=ENTITYa5c3b0&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:24:59-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1ILR46003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1ILR46003";
$('#page_loader').show().spin();
JUDGE_IDS=["3424963"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
